ABSTRACT POSTER PRESENTATIONS

At APBCS 2026, we proudly showcase cutting-edge research through our Abstract Poster Presentations, featuring innovative work from clinicians, researchers, and emerging leaders in breast cancer care across the Asia-Pacific region and beyond. This dedicated poster program highlights the latest scientific insights, real-world evidence, and translational research, fostering meaningful academic exchange and collaboration throughout the summit.

Poster Display Schedule

Viewing Only: Posters will be displayed for viewing throughout the day. No live poster presentations are scheduled.

Poster Listing — Day 1 (February 7, 2026)

Poster Title Main Author Country Panel # Submission ID
SINGLE-PORT ENDOSCOPY-ASSISTED BREAST SURGERY FOR BENIGN BREAST DISEASES: CASE SERIES Nora Minori Indonesia 1 9
DEEP INSPIRATION BREATH-HOLD TECHNIQUE FOR ALL PATIENTS WITH LEFT SIDED BREAST CANCER IN LOW RESOURCE COUNTRY- ONE SIZE OR PERSONALISED. Md Abdul Mannan Bangladesh 2 15
Initial Experience of Robot-assisted Breast Conserving Surgery Se Hyun Paek Korea South 3 16
COMPARATIVE CASE STUDY- LONG-TERM DISEASE CONTROL VS. SEQUENTIAL MULTIMODAL MANAGEMENT IN METASTATIC HR-POSITIVE, HER2-NEGATIVE BREAST CANCER-IN BANGLADESH. S.M. ASHIQUR RAHMAN SHIMUL Bangladesh 4 20
Investigating the Combining of Abemaciclib as Cyclo-Dependent Kinase 4/6 Inhibitors with Endocrine Therapy: Does the Combination Therapy Improve Outcomes in HR+/HER2- Early Breast Cancer? Aprizal Satria Indonesia 5 22
Bilateral Benign Phyllodes Tumor of the Breast: A Rare Case Report Bryan Matthew Miraflor Philippines 6 23
REAL WORLD DATA OF TOLERABILITY OF ADJUVANT ORAL ENDOCRINE THERAPY COMBINED WITH OVARIAN FUNCTION SUPPRESSION IN PREMENOPAUSAL WOMEN WITH BREAST CANCER IN CHINESE POPULATION TREATED IN A SINGLE CENTER IN HONG KONG Ngan Sum Jean Cheng Hong Kong 7 24
THE POTENTIAL OF ANTI-CTLA-4 AS BREAST CANCER IMMUNOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS IN EFFICACY AND SAFETY Felly Moelyadi Indonesia 8 25
IMMEDIATE PREPECTORAL IMPLANT RECONSTRUCTION USING POLYGLACTIN 910 (VICRYL™) MESH: A SAFE AND LOW-COST ALTERNATIVE Yuk Kwan Chang Hong Kong 9 26
CAN INTRAOPERATIVE ULTRASOUND ENSURE ONCOLOGICALLY SAFE MARGIN DURING BREAST CONSERVING SURGERY? Leea Amin Bangladesh 10 28
FACTORS AFFECTED MAMMOGRAPHY SCREENING UPTAKE AMONG SOUTHERN VIETNAMESE WOMEN Minh Thu Duong Vietnam 11 29
IMPACT OF BREAST-CONSERVING SURGERY ON BODY IMAGE: ASSESSMENT VIA THE BODY IMAGE SCALE Minh Thu Duong Vietnam 12 30
EFFICACY OF GLUE FIXATION VERSUS QUILTING SUTURES IN REDUCING EARLY SEROMA AFTER MODIFIED RADICAL MASTECTOMY (MRM): A PROSPECTIVE COMPARATIVE ANALYSIS Ishaan Wazir India 13 32
Missed Microcalcifications and Delayed Diagnosis of Invasive Breast Cancer in a Postmenopausal Woman: A Case Report on the Limitations of Mammography Moutushyi Rahman Bangladesh 14 34
The Hidden Primary: Contemporary Insights into Occult Breast Carcinoma Noor Nabila Mohamad Malaysia 15 35
RIBOCICLIB PLUS ENDOCRINE THERAPY IN VISCERAL OR RAPIDLY PROGRESSIVE HR+/HER2– METASTATIC BREAST CANCER: REAL-WORLD INSIGHTS FROM VIETNAM Thao Vu Vietnam 16 36
ONCOPLASTIC BREAST SURGERY IN BREAST CANCER CARE: A COMPREHENSIVE REVIEW OF CLINICAL, ONCOLOGICAL & PATIENT-CENTRED OUTCOMES IN A SINGLE TERTIARY CENTRE MIN YEN TAN Malaysia 17 37
CONSTRAINS AND CHALLENGES OF BREAST CONSERVING THERAPY IN BANGLADESH: MY EXPERIENCE SADIA ARMIN KHAN Bangladesh 18 38
ON THE PRESENCE OF A TENDENCY TO AVOID ASSISTANCE FROM MALE RADIOLOGIC TECHNOLOGISTS AMONG MAMMOGRAPHY PATIENTS JUN OKI Japan 19 41
A New Era of Endoscopic and Robot-Assisted Breast Surgery Using a Novel Localization Material, Luminomark Hyukjai Shin Korea South 20 47
PRIMARY BREAST LYMPHOMA: A RARE PATHOLOGICAL ENTITY Anish Bhatia India 21 48
Breast Cancer Risk Perception - Insights from BREATHE Su-Ann Goh Singapore 22 49
REAL WORLD PERFORMANCE OF THE HYBRID TUMOR-INFORMED AND TUMOR-AGNOSTIC CTDNA TESTING TO PREDICT BREAST CANCER RECURRENCE AND PROGRESSION IN SOUTHEAST ASIA Van-Anh Nguyen Hoang Vietnam 23 50
Barriers of Early Stage Breast Cancer Diagnosis in Dhaka, Bangladesh: A Patient's Perspective moutushyi rahman Bangladesh 24 52
LONG-TERM PRODUCTIVITY OUTCOMES IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS AND CAREGIVERS: A CROSS-SECTIONAL SURVEY AND MODEL-BASED ANALYSIS COMPARING STANDARD CHEMOTHERAPY WITH IMMUNOTHERAPY IN EARLY-STAGE DISEASE Sameer Gokhale India 25 53
EXPANDING BREAST CONSERVATION USING A BILOBED LATERAL ARTERY PERFORATOR-BASED TRANSPOSITION FLAP: OUR EXPERIENCE Gwendolyn Tattao Philippines 26 55
Restoring Form Without Compromise: Aesthetic and Oncologic Outcomes of Latissimus Dorsi Versus Modified Lateral Intercostal Perforators Artery (LICAP) Flaps in Breast Conservation nur aziah Adib Anuar Malaysia 27 60
Evolving Biology of Breast Cancer: A Rare Case of Metaplastic Transformation After HER2-Positive Disease NOOR HIDAYAH MOHDMONI Malaysia 28 61
BILATERAL BREAST CANCER: A CASE SERIES AND REVIEW OF CLINICAL CHARACTERISTICS Ying Li Tan Malaysia 29 62
Factors Affecting Recurrence Among Diagnosed Cases of Phyllodes Tumor: A Single Center Retrospective Cohort Study Rachelle Joanne Tugano Philippines 30 63

Poster Listing — Day 2 (February 8, 2026)

Poster Title Main Author Country Panel # Submission ID
TROFUSE-012: A PHASE 3, RANDOMIZED STUDY OF ADJUVANT SACITUZUMAB TIRUMOTECAN PLUS PEMBROLIZUMAB VS TREATMENT OF PHYSICIAN’S CHOICE IN PARTICIPANTS WITH TNBC WHO RECEIVED NEOADJUVANT THERAPY AND DID NOT ACHIEVE A PATHOLOGICAL COMPLETE RESPONSE AT SURGERY Rebecca Dent USA 1 59
TROFUSE-011: A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF SACITUZUMAB TIRUMOTECAN WITH OR WITHOUT PEMBROLIZUMAB VS TREATMENT OF PHYSICIAN’S CHOICE FOR PREVIOUSLY UNTREATED LOCALLY RECURRENT UNRESECTABLE OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER Hope S. Rugo USA 2 51
Preparing for First-in-Human Clinical Trials of a USP22-Specific Inhibitor in Patients with Advanced Triple-Negative Breast Cancer Deyu Fang USA 3 66
NEOADJUVANT LOCOREGIONAL RADIOTHERAPY ENABLING PALLIATIVE MASTECTOMY IN UNRESECTABLE DE NOVO STAGE IV LUMINAL A BREAST CANCER: A CASE REPORT Aulia Prajwalita Nareswari Rahardjo Indonesia 4 69
PROGNOSTIC IMPLICATIONS OF HER2-LOW EXPRESSION IN HORMONE RECEPTOR POSITIVE BREAST CANCER Shibu Ignatious India 5 70
TESTING RECOMMENDATIONS VS GROUND REALITY – OUR EXPERIENCE WITH GENETIC TESTING IN BREAST CANCER Saranya Parthasarathy India 6 71
BREAST CANCER IN YOUNG – A CLOSER LOOK AT WOMEN UNDER 40 Saranya Parthasarathy India 7 72
Breast-Conserving Surgery Followed by Locoregional Radiotherapy for Luminal-A Breast Cancer T2N0M0 with a Retroareolar Tumor: A Case Report Diynie Fadhilla Fahmi Indonesia 8 73
A TREATMENT MEANT TO HELP, YET IT HARMS -A CASE REPORT OF WEEKLY PACLITAXEL INDUCED PNEUMONITIS YUN XUAN YEOH Malaysia 9 74
BEYOND THE SCARS: EXPLORING BODY-IMAGE DISTURBANCES AND PSYCHOLOGICAL DISTRESS IN BREAST-CANCER SURVIVORS AFTER MASTECTOMY IN A NORTH INDIAN TERTIARY CARE CENTRE Anand Mishra India 10 75
IMPACT OF VIRAL SEROPOSITIVITY ON TUMOR AGGRESSIVENESS AND INFECTION RISK IN BREAST CANCER: INSIGHTS FROM A LMIC (LOWER AND MIDDLE INCOME COUNTRY) COHORT Kul Ranjan Singh India 11 76
Patterns of Breast-Conserving Surgery vs. Mastectomy After Neoadjuvant Therapy Across Tumour Biologies: A Single-Centre Experience nur bazlaah bahari Malaysia 12 79
Demographic and Clinicopathologic Features of Breast Cancer Patients in a Single Tertiary Hospital in the Philippines Maria Carmela Vistal Philippines 13 81
Comparative Analysis of Transverse and Sigmoid Elliptical Incisions in Mastectomy: Toward Improved Aesthetic Outcomes. Anand kumar Balakrishna Malaysia 14 83
SINGLE-DYE SENTINEL LYMPH NODE BIOPSY IN NODE-NEGATIVE EARLY BREAST CANCER: OUTCOMES FROM A RESOURCE-LIMITED HEALTHCARE SETTING Vathsal Bandaranayake Sri Lanka 15 84
YOUNG-ONSET HORMONE RECEPTOR–POSITIVE MALE BREAST CANCER IN VIETNAM: EXCEPTIONAL 36-MONTH DISEASE-FREE OUTCOME Thao Vu Vietnam 16 85
EMERGING EPIDEMIOLOGY OF POSTPARTUM BREAST CANCER: INSIGHTS FROM CLINICAL AND POPULATION DATA IN BANGLADESH Suriana Sultana Bangladesh 17 86
Artificial Intelligence–Driven Prediction of Severe Chemotherapy-Induced Neutropenia in Breast Cancer Using a Neural Network Trained on Real-World Data from a Tertiary Teaching Hospital in Thailand. Sutthipun Suriya Thailand 18 88
The use of low-fat diet to minimize seroma and drain output in obese patient undergoing breast cancer surgery – a pilot retrospective cohort pilot study BIlly Ho Hung Cheung Hong Kong 19 89
EVALUATION OF PLATELET-TO-LYMPHOCYTE RATIO (PLR) AS A NON-INVASIVE MARKER OF BONE METASTASIS IN BREAST CARCINOMA BASED ON BONE SCINTIGRAPHY Ari Ahdiatul Gozian Indonesia 20 91
Neutrophil-to-Lymphocyte Ratio (NLR) as an Early Predictor of Bone Metastasis in Breast Carcinoma Based on Bone Scintigraphy Putra Pratamadinata Indonesia 21 92
RADIOTHERAPY OMISSION AFTER BREAST-CONSERVING SURGERY IN ELDERLY EARLY BREAST CANCER: A META-ANALYSIS I Putu Gede Septiawan Saputra Indonesia 22 93
HIGH EXPRESSION MONOCARBOXYLATE TRANSPORTER 4 (MCT-4) IS ASSOCIATED WITH MALIGNANT SUBTYPE AND ADVANCED STAGE OF BREAST CANCER PATIENTS IN NGOERAH GENERAL HOSPITAL, DENPASAR, INDONESIA I Gede Putu Supadmanaba Indonesia 23 94
Survival Outcome Following Single and Dual Blockade Anti Her-2 Therapy and Related Factors among Breast Cancer Patients Mehdi Faruk Proteek | Syed Shaude Bangladesh 24 95
Coincidental of Breast Cancer and Endometrium Cancer Primasari Deaningtyas Indonesia 25 99
Luminal A Breast Cancer Survivor with Advanced Stage Endometrium Cancer Receiving Taxan Platinum Chemotherapy Primasari Deaningtyas Indonesia 26 100
Identification of Proliferation-Associated MicroRNAs as Potential Prognostic Biomarkers in Breast Cancer Dyah Dewi Indonesia 27 102
Predictors of early breast cancer related lymphoedema: a retrospective study of an early detection service Siun Walsh Ireland 28 104
A Phase 3, Randomized, Double-Blind Study Comparing a Pertuzumab Biosimilar with Reference Pertuzumab in Combination with Trastuzumab and Docetaxel in HER2-Positive Metastatic Breast Cancer Manthan Mehta India 29 43
Preliminary Evaluation of the Efficacy of Paclitaxel–Carboplatin–AC Regimen in Neoadjuvant Treatment of Triple-Negative Breast Cancer Quy Nguyen Vietnam 30 105
A global Phase III, randomized, double-blind trial of pumitamig plus chemotherapy (chemo) vs placebo plus chemo in patients (pts) Kordula Kordula Germany 31 106

Abstract Review Committee

Review Committee for Day 1

Review Committee for Day 2

Top Abstract Poster Award

To celebrate outstanding scientific contribution, APBCS 2026 proudly recognizes exceptional research through the Top Abstract Poster Award—honoring work that demonstrates innovation, clinical relevance, and meaningful impact in breast cancer care.

Award Includes:

 

This award recognizes outstanding scientific contribution and presentation quality, reinforcing APBCS’s commitment to nurturing research excellence in breast cancer care.